Sudeep Pharma IPO Analysis: Success Potential?

On: Thursday, November 27, 2025 8:52 AM
---Advertisement---

Sudeep Pharma IPO: Analyzed for Potential Success

Sudeep Pharma, a company making ingredients for medicines, is planning to start trading on the stock market on November 28, 2025. Early signs, based on trading in the ‘grey market’, suggest a positive start to its IPO. The company successfully raised a significant amount of money through its IPO, indicating strong investor confidence.

Key Points

  • Sudeep Pharma raised ₹895 crore through its IPO.
  • Investors showed huge interest, oversubscribing 93.72 times.
  • Qualified institutional buyers snapped up 213.08 times their share.
  • Non-institutional investors and retail investors also showed strong interest.
  • Grey market trading suggests a potential listing price near ₹691.
  • Grey market data is unreliable, treat with caution.

The IPO was made up of two parts: a new offering of 1.6 million shares for ₹95 crore, and an existing sale of 13.5 million shares for ₹800 crore. Investors paid an average of ₹593 per share for these shares. Before the official launch, the company also raised ₹268.5 crore from investors called “anchor investors,” showing further confidence in the company.

These anchor investors included big names like SBI Mutual Fund, HDFC MF, and others. The final decision on who gets shares was made on November 26, 2025, and now everyone is waiting for the shares to start trading on the stock market.

The money raised from the IPO will be used to buy new equipment for their factory and for general business expenses. The shares were offered at a price between ₹563 and ₹593, with each investor needing to buy at least 25 shares. ICICI Securities and IIFL Capital Services were helping manage the sale of these shares.

It’s important to remember that the “grey market” is where shares trade before they’re officially listed. While it can give an idea of how the stock might perform, it’s not always accurate. Analysts advise investors to take this information with a grain of salt.

“Investor success with Sudeep Pharma’s IPO hinges on sustained grey market trends and a broader market uptrend.”